Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization-Reference-Cited by-同舟云学术

Up-to-seven criteria as a useful predictor for tumor downstaging to within Milan criteria and Child-Pugh grade deterioration after initial conventional transarterial chemoembolization

Published:2018-02-09 Issue:6 Volume:48 Page:442-450
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Yasui Yutaka¹^ORCID,Tsuchiya Kaoru¹,Kurosaki Masayuki¹,Takeguchi Takaya²,Takeguchi Yuko²,Okada Mao¹,Wang Wan¹,Kubota Yohei¹,Goto Tomoyuki¹,Komiyama Yasuyuki¹³,Higuchi Mayu¹,Takaura Kenta¹,Hayashi Tsuguru¹⁴,Takada Hitomi¹³,Tamaki Nobuharu¹,Nakanishi Hiroyuki¹,Itakura Jun¹,Takahashi Yuka¹,Asahina Yasuhiro⁵,Enomoto Nobuyuki³,Himeno Yoshiro²,Izumi Namiki¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Musashino Red Cross Hospital; Tokyo Japan

2. Department of Radiology; Musashino Red Cross Hospital; Tokyo Japan

3. First Department of Internal Medicine; University of Yamanashi; Yamanashi Japan

4. Third Department of Internal Medicine; University of Occupational and Environmental Health; Kitakyushu Japan

5. Liver Disease Control; Tokyo Medical and Dental University; Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13048/fullpdf

Reference33 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma;Bruix;Gastroenterology,2016

3. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

4. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

5. Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions;Bolondi;Semin Liver Dis,2012

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic arterial-infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma;2024-09-09

2. Hepatic arterial infusion chemotherapy plus camrelizumab and apatinib for advanced hepatocellular carcinoma;Hepatology International;2024-07-03

3. No lipiodol, no beads—another transcatheter arterial chemoembolization (TACE) with fine cisplatin powder and porous gelatin particles for TACE‐naïve, multifocal, up‐to‐seven out hepatocellular carcinoma;Cancer Medicine;2024-07

4. Liver Transplantation for Hepatocarcinoma: Results over Two Decades of a Transplantation Programme and Analysis of Factors Associated with Recurrence;Biomedicines;2024-06-12

5. CRAFITY score benefits hepatocellular carcinoma patients treated with transarterial chemoembolization and lenvatinib;Cancer Medicine;2024-06